Positron emission tomography in patients with head and neck carcinoma

To examine the role of positron emission tomography (PET) with labeled flourodeoxyglucose (FDG) in patients with primary neoplasms of the head and neck. Between 9/92 and 9/94, forty-four FDG PET scans were performed on 27 patients with head and neck neoplasms. FDG uptake at the tumor sites was quantified with standardized uptake values (SUV).